These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

184 related articles for article (PubMed ID: 8093677)

  • 1. Photoaffinity labeling of P-glycoprotein in multidrug-resistant cells.
    Safa AR
    Cancer Invest; 1993; 11(1):46-56. PubMed ID: 8093677
    [No Abstract]   [Full Text] [Related]  

  • 2. Analysis of structural features of dihydropyridine analogs needed to reverse multidrug resistance and to inhibit photoaffinity labeling of P-glycoprotein.
    Nogae I; Kohno K; Kikuchi J; Kuwano M; Akiyama S; Kiue A; Suzuki K; Yoshida Y; Cornwell MM; Pastan I
    Biochem Pharmacol; 1989 Feb; 38(3):519-27. PubMed ID: 2563655
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Azidopine photoaffinity labeling of multidrug resistance-associated glycoproteins.
    Yang CP; Mellado W; Horwitz SB
    Biochem Pharmacol; 1988 Apr; 37(7):1417-21. PubMed ID: 2895656
    [No Abstract]   [Full Text] [Related]  

  • 4. P-glycoprotein transports corticosterone and is photoaffinity-labeled by the steroid.
    Wolf DC; Horwitz SB
    Int J Cancer; 1992 Aug; 52(1):141-6. PubMed ID: 1354202
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Multidrug resistance and its circumvention.
    Beck WT
    Eur J Cancer; 1990 Apr; 26(4):513-5. PubMed ID: 1972629
    [No Abstract]   [Full Text] [Related]  

  • 6. Multidrug resistance in human cancer.
    Goldstein LJ; Pastan I; Gottesman MM
    Crit Rev Oncol Hematol; 1992; 12(3):243-53. PubMed ID: 1353966
    [No Abstract]   [Full Text] [Related]  

  • 7. Liposome-mediated modulation of multidrug resistance in human HL-60 leukemia cells.
    Rahman A; Husain SR; Siddiqui J; Verma M; Agresti M; Center M; Safa AR; Glazer RI
    J Natl Cancer Inst; 1992 Dec; 84(24):1909-15. PubMed ID: 1361008
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The alpha 1-adrenergic photoaffinity probe [125I]arylazidoprazosin binds to a specific peptide of P-glycoprotein in multidrug-resistant cells.
    Safa AR; Agresti M; Tamai I; Mehta ND; Vahabi S
    Biochem Biophys Res Commun; 1990 Jan; 166(1):259-66. PubMed ID: 1967938
    [TBL] [Abstract][Full Text] [Related]  

  • 9. ATP-binding properties of P glycoprotein from multidrug-resistant KB cells.
    Cornwell MM; Tsuruo T; Gottesman MM; Pastan I
    FASEB J; 1987 Jul; 1(1):51-4. PubMed ID: 2886389
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Mechanism of multidrug resistance.
    Bradley G; Juranka PF; Ling V
    Biochim Biophys Acta; 1988 Aug; 948(1):87-128. PubMed ID: 2899442
    [No Abstract]   [Full Text] [Related]  

  • 11. Steroid hormones inhibit binding of Vinca alkaloid to multidrug resistance related P-glycoprotein.
    Naito M; Yusa K; Tsuruo T
    Biochem Biophys Res Commun; 1989 Feb; 158(3):1066-71. PubMed ID: 2563940
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effects of indole alkaloids on multidrug resistance and labeling of P-glycoprotein by a photoaffinity analog of vinblastine.
    Beck WT; Cirtain MC; Glover CJ; Felsted RL; Safa AR
    Biochem Biophys Res Commun; 1988 Jun; 153(3):959-66. PubMed ID: 2898941
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The clinical relevance of multidrug resistance.
    Bellamy WT; Dalton WS; Dorr RT
    Cancer Invest; 1990; 8(5):547-62. PubMed ID: 1979932
    [No Abstract]   [Full Text] [Related]  

  • 14. Major photoaffinity drug labeling sites for iodoaryl azidoprazosin in P-glycoprotein are within, or immediately C-terminal to, transmembrane domains 6 and 12.
    Greenberger LM
    J Biol Chem; 1993 May; 268(15):11417-25. PubMed ID: 8098711
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A new paclitaxel photoaffinity analog with a 3-(4-benzoylphenyl)propanoyl probe for characterization of drug-binding sites on tubulin and P-glycoprotein.
    Ojima I; Duclos O; Dormán G; Simonot B; Prestwich GD; Rao S; Lerro KA; Horwitz SB
    J Med Chem; 1995 Sep; 38(20):3891-4. PubMed ID: 7562921
    [No Abstract]   [Full Text] [Related]  

  • 16. Multidrug resistance and P-glycoprotein expression.
    Ling V
    Ann N Y Acad Sci; 1987; 507():7-8. PubMed ID: 2894794
    [No Abstract]   [Full Text] [Related]  

  • 17. N-(p-azido-3-[125I]iodophenethyl)spiperone binds to specific regions of P-glycoprotein and another multidrug binding protein, spiperophilin, in human neuroblastoma cells.
    Safa AR; Agresti M; Bryk D; Tamai I
    Biochemistry; 1994 Jan; 33(1):256-65. PubMed ID: 7904476
    [TBL] [Abstract][Full Text] [Related]  

  • 18. P glycoprotein (P-gp) and drug resistance--time for reappraisal?
    Kaye SB
    Br J Cancer; 1993 Apr; 67(4):641-3. PubMed ID: 8097103
    [No Abstract]   [Full Text] [Related]  

  • 19. Cyclosporin A enhances susceptibility of multi-drug resistant human cancer cells to anti-P-glycoprotein antibody-dependent cytotoxicity of monocytes, but not of lymphocytes.
    Yano S; Sone S; Nishioka Y; Naito M; Tsuruo T; Ogura T
    Jpn J Cancer Res; 1994 Feb; 85(2):194-203. PubMed ID: 7511575
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Two different regions of P-glycoprotein [corrected] are photoaffinity-labeled by azidopine.
    Bruggemann EP; Germann UA; Gottesman MM; Pastan I
    J Biol Chem; 1989 Sep; 264(26):15483-8. PubMed ID: 2475500
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.